The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oral Solid Dosage Contract Manufacturing Market Research Report 2024
Synopsis
The global Oral Solid Dosage Contract Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral Solid Dosage Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Solid Dosage Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oral Solid Dosage Contract Manufacturing in Specialty/Midsize is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oral Solid Dosage Contract Manufacturing include Catalent, DPx, Lonza Group (Capsugel), Piramal Pharma Solutions, Aenova, Jubilant, Famar, Boehringer Ingelheim and Fareva Holding, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Solid Dosage Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Solid Dosage Contract Manufacturing.
Report Scope
The Oral Solid Dosage Contract Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Solid Dosage Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Solid Dosage Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
DPx
Lonza Group (Capsugel)
Piramal Pharma Solutions
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie Contract Manufacturing
Nipro Pharma
Sopharma
Mylan (DPT Laboratories)
Recipharm
NextPharma
Dishman
Aesica Pharmaceuticals
CordenPharma
Segment by Type
Tablets
Capsules
Powders & Granules
Others
Segment by Application
Specialty/Midsize
Generics
Big Pharma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Solid Dosage Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Oral Solid Dosage Contract Manufacturing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Oral Solid Dosage Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Oral Solid Dosage Contract Manufacturing is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Oral Solid Dosage Contract Manufacturing in Specialty/Midsize is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Oral Solid Dosage Contract Manufacturing include Catalent, DPx, Lonza Group (Capsugel), Piramal Pharma Solutions, Aenova, Jubilant, Famar, Boehringer Ingelheim and Fareva Holding, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Oral Solid Dosage Contract Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Solid Dosage Contract Manufacturing.
Report Scope
The Oral Solid Dosage Contract Manufacturing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Solid Dosage Contract Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Solid Dosage Contract Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
DPx
Lonza Group (Capsugel)
Piramal Pharma Solutions
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie Contract Manufacturing
Nipro Pharma
Sopharma
Mylan (DPT Laboratories)
Recipharm
NextPharma
Dishman
Aesica Pharmaceuticals
CordenPharma
Segment by Type
Tablets
Capsules
Powders & Granules
Others
Segment by Application
Specialty/Midsize
Generics
Big Pharma
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Solid Dosage Contract Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Solid Dosage Contract Manufacturing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tablets
1.2.3 Capsules
1.2.4 Powders & Granules
1.2.5 Others
1.3 Market by Application
1.3.1 Global Oral Solid Dosage Contract Manufacturing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Specialty/Midsize
1.3.3 Generics
1.3.4 Big Pharma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Solid Dosage Contract Manufacturing Market Perspective (2019-2030)
2.2 Oral Solid Dosage Contract Manufacturing Growth Trends by Region
2.2.1 Global Oral Solid Dosage Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Oral Solid Dosage Contract Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Oral Solid Dosage Contract Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Oral Solid Dosage Contract Manufacturing Market Dynamics
2.3.1 Oral Solid Dosage Contract Manufacturing Industry Trends
2.3.2 Oral Solid Dosage Contract Manufacturing Market Drivers
2.3.3 Oral Solid Dosage Contract Manufacturing Market Challenges
2.3.4 Oral Solid Dosage Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Solid Dosage Contract Manufacturing Players by Revenue
3.1.1 Global Top Oral Solid Dosage Contract Manufacturing Players by Revenue (2019-2024)
3.1.2 Global Oral Solid Dosage Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Oral Solid Dosage Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Solid Dosage Contract Manufacturing Revenue
3.4 Global Oral Solid Dosage Contract Manufacturing Market Concentration Ratio
3.4.1 Global Oral Solid Dosage Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Contract Manufacturing Revenue in 2023
3.5 Oral Solid Dosage Contract Manufacturing Key Players Head office and Area Served
3.6 Key Players Oral Solid Dosage Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Oral Solid Dosage Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Solid Dosage Contract Manufacturing Breakdown Data by Type
4.1 Global Oral Solid Dosage Contract Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Oral Solid Dosage Contract Manufacturing Forecasted Market Size by Type (2025-2030)
5 Oral Solid Dosage Contract Manufacturing Breakdown Data by Application
5.1 Global Oral Solid Dosage Contract Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Oral Solid Dosage Contract Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Oral Solid Dosage Contract Manufacturing Market Size (2019-2030)
6.2 North America Oral Solid Dosage Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Oral Solid Dosage Contract Manufacturing Market Size by Country (2019-2024)
6.4 North America Oral Solid Dosage Contract Manufacturing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Solid Dosage Contract Manufacturing Market Size (2019-2030)
7.2 Europe Oral Solid Dosage Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Oral Solid Dosage Contract Manufacturing Market Size by Country (2019-2024)
7.4 Europe Oral Solid Dosage Contract Manufacturing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size (2019-2030)
8.2 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Region (2019-2024)
8.4 Asia-Pacific Oral Solid Dosage Contract Manufacturing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Solid Dosage Contract Manufacturing Market Size (2019-2030)
9.2 Latin America Oral Solid Dosage Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Country (2019-2024)
9.4 Latin America Oral Solid Dosage Contract Manufacturing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size (2019-2030)
10.2 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Country (2019-2024)
10.4 Middle East & Africa Oral Solid Dosage Contract Manufacturing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Oral Solid Dosage Contract Manufacturing Introduction
11.1.4 Catalent Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 DPx
11.2.1 DPx Company Detail
11.2.2 DPx Business Overview
11.2.3 DPx Oral Solid Dosage Contract Manufacturing Introduction
11.2.4 DPx Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.2.5 DPx Recent Development
11.3 Lonza Group (Capsugel)
11.3.1 Lonza Group (Capsugel) Company Detail
11.3.2 Lonza Group (Capsugel) Business Overview
11.3.3 Lonza Group (Capsugel) Oral Solid Dosage Contract Manufacturing Introduction
11.3.4 Lonza Group (Capsugel) Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.3.5 Lonza Group (Capsugel) Recent Development
11.4 Piramal Pharma Solutions
11.4.1 Piramal Pharma Solutions Company Detail
11.4.2 Piramal Pharma Solutions Business Overview
11.4.3 Piramal Pharma Solutions Oral Solid Dosage Contract Manufacturing Introduction
11.4.4 Piramal Pharma Solutions Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.4.5 Piramal Pharma Solutions Recent Development
11.5 Aenova
11.5.1 Aenova Company Detail
11.5.2 Aenova Business Overview
11.5.3 Aenova Oral Solid Dosage Contract Manufacturing Introduction
11.5.4 Aenova Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.5.5 Aenova Recent Development
11.6 Jubilant
11.6.1 Jubilant Company Detail
11.6.2 Jubilant Business Overview
11.6.3 Jubilant Oral Solid Dosage Contract Manufacturing Introduction
11.6.4 Jubilant Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.6.5 Jubilant Recent Development
11.7 Famar
11.7.1 Famar Company Detail
11.7.2 Famar Business Overview
11.7.3 Famar Oral Solid Dosage Contract Manufacturing Introduction
11.7.4 Famar Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.7.5 Famar Recent Development
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Detail
11.8.2 Boehringer Ingelheim Business Overview
11.8.3 Boehringer Ingelheim Oral Solid Dosage Contract Manufacturing Introduction
11.8.4 Boehringer Ingelheim Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.8.5 Boehringer Ingelheim Recent Development
11.9 Fareva Holding
11.9.1 Fareva Holding Company Detail
11.9.2 Fareva Holding Business Overview
11.9.3 Fareva Holding Oral Solid Dosage Contract Manufacturing Introduction
11.9.4 Fareva Holding Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.9.5 Fareva Holding Recent Development
11.10 AbbVie Contract Manufacturing
11.10.1 AbbVie Contract Manufacturing Company Detail
11.10.2 AbbVie Contract Manufacturing Business Overview
11.10.3 AbbVie Contract Manufacturing Oral Solid Dosage Contract Manufacturing Introduction
11.10.4 AbbVie Contract Manufacturing Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.10.5 AbbVie Contract Manufacturing Recent Development
11.11 Nipro Pharma
11.11.1 Nipro Pharma Company Detail
11.11.2 Nipro Pharma Business Overview
11.11.3 Nipro Pharma Oral Solid Dosage Contract Manufacturing Introduction
11.11.4 Nipro Pharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.11.5 Nipro Pharma Recent Development
11.12 Sopharma
11.12.1 Sopharma Company Detail
11.12.2 Sopharma Business Overview
11.12.3 Sopharma Oral Solid Dosage Contract Manufacturing Introduction
11.12.4 Sopharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.12.5 Sopharma Recent Development
11.13 Mylan (DPT Laboratories)
11.13.1 Mylan (DPT Laboratories) Company Detail
11.13.2 Mylan (DPT Laboratories) Business Overview
11.13.3 Mylan (DPT Laboratories) Oral Solid Dosage Contract Manufacturing Introduction
11.13.4 Mylan (DPT Laboratories) Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.13.5 Mylan (DPT Laboratories) Recent Development
11.14 Recipharm
11.14.1 Recipharm Company Detail
11.14.2 Recipharm Business Overview
11.14.3 Recipharm Oral Solid Dosage Contract Manufacturing Introduction
11.14.4 Recipharm Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.14.5 Recipharm Recent Development
11.15 NextPharma
11.15.1 NextPharma Company Detail
11.15.2 NextPharma Business Overview
11.15.3 NextPharma Oral Solid Dosage Contract Manufacturing Introduction
11.15.4 NextPharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.15.5 NextPharma Recent Development
11.16 Dishman
11.16.1 Dishman Company Detail
11.16.2 Dishman Business Overview
11.16.3 Dishman Oral Solid Dosage Contract Manufacturing Introduction
11.16.4 Dishman Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.16.5 Dishman Recent Development
11.17 Aesica Pharmaceuticals
11.17.1 Aesica Pharmaceuticals Company Detail
11.17.2 Aesica Pharmaceuticals Business Overview
11.17.3 Aesica Pharmaceuticals Oral Solid Dosage Contract Manufacturing Introduction
11.17.4 Aesica Pharmaceuticals Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.17.5 Aesica Pharmaceuticals Recent Development
11.18 CordenPharma
11.18.1 CordenPharma Company Detail
11.18.2 CordenPharma Business Overview
11.18.3 CordenPharma Oral Solid Dosage Contract Manufacturing Introduction
11.18.4 CordenPharma Revenue in Oral Solid Dosage Contract Manufacturing Business (2019-2024)
11.18.5 CordenPharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
